HOUSTON INNOVATORS PODCAST EPISODE 22

Houston energy tech startup talks growth and national expansion following $5.5M series A

Adam Gilles and Lance Richardson, co-founders of Hitched Inc., join this week's episode of the Houston Innovators Podcast to discuss the digital marketplace's rapid growth. Photos courtesy of Hitched

Industrial operations might be a bit behind in technology advances, but that's going to start changing, according to Adam Gilles, CEO and co-founder of Houston-based Hitched Inc.

The software-as-a-service company acts as a digital marketplace and management solution for service providers renting industrial equipment. It's a platform not too unfamiliar for Airbnb — users can quickly rent machinery online without even having to pick up a phone and talk to anyone.

"I think streamline oil and gas is what everyone is trying to do," Gilles says on the industry's technology evolution. "I've always said that industrial technology will follow the path of consumer technology."

Gilles and his COO and co-founder, Lance Richardson, join this week's episode of the Houston Innovators Podcast to discuss the technology and Hitched's rapid growth and lofty goals.

"Change for a startup is like eating breakfast," Richardson says on the podcast. "Ultimately, [our goal] is to be the marketplace management tool for all of oil and gas."

Since its founding in 2018, Hitched has expanded throughout Texas and its surrounding states, with more expansion on the horizon. A recent $5.5 million series A round led by Houston-based Cottonwood Venture Partners has upped the ante on hiring new salespeople — Gilles says his team will grow to 50 people by the end of the year.

For now, Hitched rents out equipment within the oil and gas industry — where Gilles and Richardson have experience in — but the company will expand into other industrial sectors.

"As we've built this technology, it's industry agnostic," Gilles says. "Energy was the low-hanging fruit for us being that we've been in the industry for 10 years now with our contacts and what not, but frankly it makes sense for us to move into those other spaces."

Neither Gilles or Richardson are Houston natives — both recently relocated to give Hitched its best shot as a fast-growing, ready-for-scale tech company.

"Houston will always be the energy capital of the world, but as energy innovates, there's a good chance it will become a technology hub as well," Gilles says. "I can't see why a technology firm in the energy space wouldn't be based in Houston. It's just doesn't make sense to me."

Listen to the full episode below — or wherever you get your podcasts — and subscribe for weekly episodes.


Trending News

Building Houston

 
 

From biomolecular research to oral cancer immunotherapy, here are three research projects to watch out for in Houston. Photo via Getty Images

Research, perhaps now more than ever, is crucial to expanding and growing innovation in Houston — and it's happening across the city right under our noses.

In InnovationMap's latest roundup of research news, a couple local scientists are honored by awards while another duo of specialists tackle a new project.

University of Houston professor recognized with award

Mehmet Orman of UH has been selected to receive an award for his research on persister cells. Photo via UH.edu

Mehmet Orman, assistant professor of chemical and biomolecular engineering at the University of Houston Cullen College of Engineering has been honored with a Faculty Early Career Development Award from the National Science Foundation. The award comes with a $500,000 grant to study persister cells — cells that go dormant and then become tolerant to extraordinary levels of antibiotics.

"Nearly all bacterial cultures contain a small population of persister cells," says Orman in a news release. "Persisters are thought to be responsible for recurring chronic infections such as those of the urinary tract and for creating drug-resistant mutants."

Previously, Orman developed the first methods to directly measure the metabolism of persister cells. He also developed cell sorting strategies to segregate persisters from highly heterogeneous bacterial cell populations, and, according to the release, he will be using his methods in the NSF research project.

Houston researchers collaborate on oral cancer innovation

Dr. Simon Young of UTHealth and Jeffrey Hartgerink of Rice University are working on a new use for an innovative gel they developed. Photo via Rice.edu

Two Houston researchers — chemist and bioengineer Jeffrey Hartgerink at Rice University and Dr. Simon Young at the University of Texas Health Science Center at Houston — have again teamed up to advance their previous development of a sophisticated hydrogel called STINGel. This time, they are using it to destroy oral cancer tumors.

SynerGel combines a pair of antitumor agents into a gel that can be injected directly into tumors. Once there, the gel controls the release of its cargo to not only trigger cells' immune response but also to remove other suppressive immune cells from the tumor's microenvironment. The duo reported on the technology in the American Chemical Society journal ACS Biomaterials Science & Engineering.

SynerGel, combines a pair of antitumor agents into a gel that can be injected directly into tumors, where they not only control the release of the drugs but also remove suppressive immune cells from the tumor's microenvironment.

"We are really excited about this new material," Hartgerink says in a news release. "SynerGel is formulated from a specially synthesized peptide which itself acts as an enzyme inhibitor, but it also assembles into a nanofibrous gel that can entrap and release other drugs in a controlled fashion.

In 2018, the pair published research on the use of a multidomain peptide gel — the original STINGel — to deliver ADU-S100, an immunotherapy drug from a class of "stimulator of interferon gene (STING) agonists."

The research is supported by the Oral and Maxillofacial Surgery Foundation, the National Institutes of Health, the Welch Foundation, the National Science Foundation and the Mexican National Council for Science and Technology.

Texas Heart Institute researcher honored by national organization

Dr. James Martin of Texas Heart Institute has been named a senior member of the National Academy of Inventors. Photo courtesy of THI

The National Academy of Inventors have named Houston-based Texas Heart Institute's Dr. James Martin, director of the Cardiomyocyte Renewal Lab, a senior member.

Martin is an internationally recognized developmental and regenerative biologist and his research is focused on understanding how signaling pathways are related to development and tissue regeneration.

"Dr. Martin has long been a steward of scientific advancement and has proven to be a tremendous asset to the Texas Heart Institute and to its Cardiomyocyte Renewal Lab through his efforts to translate fundamental biological discoveries in cardiac development and disease into novel treatment strategies for cardiac regeneration," says Dr. Darren Woodside, vice president for research at THI, in a news release. "Everyone at the Texas Heart Institute is thrilled for Dr. Martin, whose induction into the NAI as a Senior Member is well-deserved."

Martin has authored over 170 peer-reviewed papers in top journals he holds nine U.S. patents and applications, including one provisional application, all of which have been licensed to Yap Therapeutics, a company he co-founded.

The full list of incoming NAI Senior Members, which includes three professionals from the University of Houston, is available on the NAI website.

Trending News